Donald Bergstrom, an insider at Relay Therapeutics, Inc. (NASDAQ: RLAY), sold 2,686 shares of the company’s stock on January 28th. The shares were sold at an average price of $8.45 per share, resulting in a total transaction value of approximately $22,697.
After the sale, Bergstrom retains ownership of 420,047 shares in Relay Therapeutics. No additional details about the reason for the sale were disclosed.
**Why this matters**
Insider transactions can provide insights into the confidence company executives have in their stock. While a sale does not necessarily indicate negative outlooks, investors often monitor such activities as part of their decision-making process.